| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30002507 | HIV | ENSG00000087263.17 | protein_coding | OGFOD1 | No | No | 55239 | Q8N543 |
| TVIS30041121 | HIV | ENSG00000087263.17 | protein_coding | OGFOD1 | No | No | 55239 | Q8N543 |
| TVIS30041122 | HIV | ENSG00000087263.17 | protein_coding | OGFOD1 | No | No | 55239 | Q8N543 |
| TVIS30041123 | HIV | ENSG00000087263.17 | protein_coding | OGFOD1 | No | No | 55239 | Q8N543 |
| TVIS44030686 | HTLV-1 | ENSG00000087263.17 | protein_coding | OGFOD1 | No | No | 55239 | Q8N543 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | OGFOD1 |
|---|---|
| DrugBank ID | DB00126 |
| Drug Name | Ascorbic acid |
| Target ID | BE0002210 |
| UniProt ID | Q8N543 |
| Regulation Type | cofactor |
| PubMed IDs | 25540771 |
| Citations | Kuiper C, Vissers MC: Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression. Front Oncol. 2014 Dec 10;4:359. doi: 10.3389/fonc.2014.00359. eCollection 2014. |
| Groups | Approved; Nutraceutical |
| Direct Classification | Butenolides |
| SMILES | [H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO |
| Pathways | Tyrosine Metabolism; Refsum Disease; The Oncogenic Action of Succinate; Disulfiram Action Pathway; Aromatic L-Aminoacid Decarboxylase Deficiency; Oxidation of Branched-Chain Fatty Acids; Catecholamine Biosynthesis; Monoamine Oxidase-A Deficiency (MAO-A); Tyrosinemia, Transient, of the Newborn; Carnitine Synthesis; Phytanic Acid Peroxisomal Oxidation; Hawkinsinuria; Dopamine beta-Hydroxylase Deficiency; Tyrosinemia Type I; Alkaptonuria; Tyrosine Hydroxylase Deficiency; The Oncogenic Action of Fumarate |
| PharmGKB | PA451898 |
| ChEMBL | CHEMBL196 |
